Enhancing angiogenesis in invasive aspergillosis: A novel therapeutic approach

Journal of Infectious Diseases

Volumn 207, Issue 7, 2013, Pages 1031-1033

  Ito, James I ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

angiogenesis; aspergillosis; bFGF; proangiogenic growth factors; VEGF

Indexed keywords

AMPHOTERICIN B; CORTICOSTEROID; CORTISONE; CYCLOPHOSPHAMIDE; FIBROBLAST GROWTH FACTOR 2; GLIOTOXIN; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ACUTE LEUKEMIA; ANTIANGIOGENIC ACTIVITY; ASPERGILLUS FUMIGATUS; CONIDIUM; CORTICOSTEROID THERAPY; FUNGUS HYPHAE; GRAFT RECIPIENT; GRAFT VERSUS HOST REACTION; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HOST; HUMAN; IMMUNOCOMPETENCE; IMMUNOSUPPRESSIVE TREATMENT; INVASIVE ASPERGILLOSIS; LYMPHOMA; MORTALITY; MULTIPLE MYELOMA; MYELODYSPLASTIC SYNDROME; NEUTROPENIA; NONHUMAN; NOTE; PATHOGENESIS; PATHOPHYSIOLOGY; PERFUSION; PRIORITY JOURNAL; SURVIVAL RATE; TISSUE NECROSIS;

ANGIOGENESIS INDUCING AGENTS; ANIMALS; ANTIFUNGAL AGENTS; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; FEMALE; FIBROBLAST GROWTH FACTOR 2; HUMANS; NEOVASCULARIZATION, PHYSIOLOGIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84874733452     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jis944     Document Type: Note

References (16)

1. Pagano L, Caira M, Candoni A, et al. The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study. Haematologica 2006; 91:1068-75. (Pubitemid 44208634)
2. Baddley JW, Andes DR, Marr KA, et al. Factors associated with mortality in transplant patients with invasive aspergillosis. Clin Infect Dis 2010; 50:1559-67.
3. Pagano L, Caira M, Nosari A, et al. Fungal infections in recipients of hematopoietic stem cell transplants: results of the SEIFEM B-2004 study - Sorveglianza Epidemiologica Infezioni Fungine Nelle Emopatie Maligne. Clin Infect Dis 2007; 45:1161-70. (Pubitemid 47580314)
4. Kamai Y, Chiang LY, Lopes Bezerra LM, et al. Interactions of Aspergillus fumigatus with vascular endothelial cells. Med Mycol 2006; 44(Suppl 1):S115-7.
5. Stergiopoulou T, Meletiadis J, Roilides E, et al. Host-dependent patterns of tissue injury in invasive pulmonary aspergillosis. Am J Clin Pathol 2007; 127: 349-55. (Pubitemid 46806327)
6. Potente M, Gerhardt H, Carmeliet P. Basic and therapeutic aspects of angiogenesis. Cell 2011; 146:873-87.
7. Chiang LY, Sheppard DC, Gravelat FN, Patterson TF, Filler SG. Aspergillus fumigatus stimulates leukocyte adhesion molecules and cytokine production by endothelial cells in vitro and during invasive pulmonary disease. Infect Immun 2008; 76:3429-38.
8. Yoshida S, Ono M, Shono T, et al. Involvement of interleukin-8, vascular endothelial growth factor, and basic fibroblast growth factor in tumor necrosis factor alphadependent angiogenesis. Mol Cell Biol 1997; 17:4015-23. (Pubitemid 27281877)
9. Asami Y, Kakeya H, Okada G, Toi M, Osada H. RK-95113, a new angiogenesis inhibitor produced by Aspergillus fumigatus. J Antibiot (Tokyo) 2006; 59:724-8. (Pubitemid 46065468)
10. Ingber D, Fujita T, Kishimoto S, et al. Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth. Nature 1990; 348:555-7. (Pubitemid 120015110)
11. Lee HJ, Lee JH, Hwang BY, Kim HS, Lee JJ. Anti-angiogenic activities of gliotoxin and its methylthioderivative, fungal metabolites. Arch Pharm Res 2001; 24:397-401. (Pubitemid 33647256)
12. Sin N, Meng L, Wang MQ, Wen JJ, Bornmann WG, Crews CM. The antiangiogenic agent fumagillin covalently binds and inhibits the methionine aminopeptidase, MetAP-2. Proc Natl Acad Sci U S A 1997; 94:6099-103. (Pubitemid 27270643)
13. Ben-Ami R, Lewis RE, Leventakos K, Kontoyiannis DP. Aspergillus fumigatus inhibits angiogenesis through the production of gliotoxin and other secondary metabolites. Blood 2009; 114:5393-9.
14. Ben-Ami R, Albert ND, Lewis RE, Kontoyiannis DP. Proangiogenic growth factors potentiate in situ angiogenesis and enhance antifungal drug activity in murine invasive aspergillosis. J Infect Dis 2013; 207.
15. Paciaroni M, Bogousslavsky J. Trafermin for stroke recovery: is it time for another randomized clinical trial?. Expert Opin Biol Ther 2011; 11:1533-41.
16. Moehler TM, Ho AD, Goldschmidt H, Barlogie B. Angiogenesis in hematologic malignancies. Crit Rev Oncol Hematol 2003; 45:227-44. (Pubitemid 36299132)